Who founded AlzProtect?

AlzProtect was founded by Philippe Verwaerde.

Who are AlzProtect's investors?

AlzProtect's investors include Xerys, Bpifrance.

Where is AlzProtect headquartered?

AlzProtect is headquartered in Lille, FR.

AlzProtect

Lille, FR · 2 known investors

Find your way into AlzProtect

Paths you didn't know you had: your email and LinkedIn already hold routes to the AlzProtect team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.

Biotech Healthtech

Founders & leadership

Philippe VerwaerdePresident & Chief Science OfficerPhilippe Verwaerde is President and Chief Science Officer of AlzProtect, a biotech company developing therapeutics for neurodegenerative diseases. He has held leadership roles in drug discovery across multiple therapeutic areas including inflammation, cardiovascular, anti-infectives, cancer, CNS, and metabolic diseases, with expertise spanning chemistry, biology, and translational development from preclinical through clinical phases.

Investors · 2

Xeryslisted by XerysParis · $16M – $97M

How we know: Xerys's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

BpifrancereportedParis, Ile-De-France · $270K

How we know: funding news · Not right? Tell us

Frequently asked questions

What does AlzProtect do?: Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
Who founded AlzProtect?: AlzProtect was founded by Philippe Verwaerde.
Who are AlzProtect's investors?: AlzProtect's investors include Xerys, Bpifrance.
Where is AlzProtect headquartered?: AlzProtect is headquartered in Lille, FR.